13F-HR filed by Deep Track Capital, LP
Deep Track Capital, LP filed this 13F-HR for the quarter ended 2024-12-31, filed 2025-02-14, with 63 holding rows worth $2,681,037,164.
- Accession
- 0001856083-25-000001
- Filer
- CIK 1856083
- Filed
- 2025-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2024
A holdings report, 63 entries on the cover page, a total value of $2,681,037,164 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,681,037,164 with VALUE read as dollars as filed, 13F file number 028-21949. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| DYNAVAX TECHNOLOGIES CORP | 268158201 | COM NEW | 17,791,486 | $227,197,276 | dollars as filed | |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 6,419,566 | $196,117,741 | dollars as filed | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 2,000,000 | $167,040,000 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 6,000,000 | $148,620,000 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 4,274,921 | $136,412,729 | dollars as filed | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 3,460,756 | $125,037,114 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 2,500,000 | $117,600,000 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 12,836,282 | $109,621,848 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 4,522,741 | $86,700,945 | dollars as filed | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 5,972,257 | $78,654,625 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 2,800,000 | $75,936,000 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 1,933,928 | $67,610,123 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 3,000,000 | $56,520,000 | dollars as filed | |
| MBX BIOSCIENCES INC COM | 55287L101 | Stock | 3,018,935 | $55,638,972 | dollars as filed | |
| 89BIO INC | 282559103 | COM | 6,478,249 | $50,659,907 | dollars as filed | |
| HARMONY BIOSCIENCES HLDGS IN | 413197104 | COM | 1,450,000 | $49,894,500 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 2,000,000 | $47,120,000 | dollars as filed | |
| SEPTERNA INC COM | 81734D104 | Stock | 1,912,929 | $43,806,074 | dollars as filed | |
| NEUMORA THERAPEUTICS INC. | 640979100 | COM | 4,000,000 | $42,400,000 | dollars as filed | |
| GENMAB A/S | 372303206 | Ordinary Shares, nominal value DKK 1 per share | 2,000,000 | $41,740,000 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 1,490,000 | $41,451,800 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 850,000 | $39,474,000 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 1,540,132 | $38,919,136 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 1,000,000 | $38,600,000 | dollars as filed | |
| ANI PHARMACEUTICALS INC | 00182C103 | COM | 649,042 | $35,879,042 | dollars as filed | |
| BICARA THERAPEUTICS INC | 055477103 | COM | 2,000,000 | $34,840,000 | dollars as filed | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 14,218,903 | $33,414,422 | dollars as filed | |
| KORRO BIO INC | 500946108 | COMMON STOCK | 874,614 | $33,296,555 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 5,576,558 | $30,894,131 | dollars as filed | |
| ENGENE HOLDINGS INC | 29286M105 | COM | 4,557,575 | $30,307,874 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 653,513 | $27,493,292 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 3,579,209 | $26,199,810 | dollars as filed | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 1,350,000 | $22,612,500 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 819,162 | $22,477,805 | dollars as filed | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 780,778 | $21,471,395 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 3,442,833 | $20,071,716 | dollars as filed | |
| MIND MEDICINE MINDMED INC | 60255C885 | COM NEW | 2,816,594 | $19,603,494 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 710,421 | $18,968,241 | dollars as filed | |
| BICYCLE THERAPEUTICS PLC-ADR | 088786108 | SPONSORED ADS | 1,276,081 | $17,865,134 | dollars as filed | |
| UPSTREAM BIO INC | 91678A107 | COMMON STOCK | 1,000,000 | $16,440,000 | dollars as filed | |
| NOVAVAX INC | 670002401 | COM NEW | 2,000,000 | $16,080,000 | dollars as filed | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 519,376 | $15,321,592 | dollars as filed | |
| ORUKA THERAPEUTICS INC COM | 687604108 | Stock | 750,000 | $14,542,500 | dollars as filed | |
| GERON CORP | 374163103 | COM | 4,011,287 | $14,199,956 | dollars as filed | |
| CYBIN INC | 23256X407 | COM NEW | 1,529,987 | $13,494,485 | dollars as filed | |
| NEUMORA THERAPEUTICS INC. | 640979100 | COM | 1,189,800 | $12,611,880 | dollars as filed | call |
| XENCOR INC | 98401F105 | COMMON STOCK | 500,000 | $11,490,000 | dollars as filed | |
| ALIGOS THERAPEUTICS INC | 01626L204 | COM NEW | 244,110 | $9,725,342 | dollars as filed | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 6,011,380 | $9,497,980 | dollars as filed | |
| ZURA BIO LTD | G9TY5A101 | COMMON STOCK | 3,283,783 | $8,209,458 | dollars as filed | |
| CONTEXT THERAPEUTICS INC | 21077P108 | COM | 7,419,355 | $7,790,323 | dollars as filed | |
| ALLAKOS INC | 01671P100 | COM | 5,704,282 | $6,902,181 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 169,132 | $6,629,974 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 867,000 | $6,441,810 | dollars as filed | |
| INOVIO PHARMACEUTICALS I | 45773H409 | COMMON STOCK | 3,119,162 | $5,708,066 | dollars as filed | |
| REGULUS THERAPEUTICS INC | 75915K309 | COM | 3,262,564 | $5,154,851 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 219,015 | $5,098,669 | dollars as filed | |
| INVIVYD INC | 00534A102 | COMMON STOCK | 10,689,603 | $4,736,563 | dollars as filed | |
| ONKURE THERAPEUTICS INC | 68277Q105 | COM CL A | 523,989 | $4,506,305 | dollars as filed | |
| 4D MOLECULAR THERAPEUTICS INC COM | 35104E100 | Stock | 609,900 | $3,397,143 | dollars as filed | |
| CLIMB BIO INC | 28658R106 | COMMON STOCK | 1,040,115 | $1,872,207 | dollars as filed | |
| NEKTAR THERAPEUTICS | 640268108 | COM | 1,975,998 | $1,837,678 | dollars as filed | |
| FILANA THERAPEUTICS INC | 14817C107 | CMN | 500,000 | $1,180,000 | dollars as filed | put |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001856083-25-000001 | this filing | 2025-02-14 | acceptance time not in the bulk data set |